Is Molina Healthcare Stock below the S&P 500 performance?
Molina Healthcare, Inc. valued at a market capitalization of $16 billion. (MOH) is a provider of healthcare services managed under the Medicaid and Medicare programs and through the state insurance market. Headquartered in Long Beach, California, the company operates in four segments, including Medicaid, Medicare and Marketplace.
Companies worth more than $10 billion are generally labelled as “large” stocks, and Molina Healthcare meets this standard perfectly. The company focuses on underserved communities and operates health plans in multiple US states. It emphasizes cost-effective and quality medical access to patients.
Molina Healthcare stock fell 19.1% from its 52-week high from $365.23. MOH stocks have fallen 6.9% over the past three months, slightly below the S&P 500 Index ($SPX) 6.5% increase.
In the long term, Molina Healthcare stock has soaked 3.5% over the last 52 weeks, lagging behind the 9% return on SPX in the same time frame. Additionally, MOH stocks achieved 1.5% on a YTD basis, while SPX is up 1.7%.
Stocks have been below the 50- and 200-day moving averages since late May.
Molina Healthcare shares fell 5.5%, following the results in the first quarter 2025 on April 23rd. The company reported revenue of $11.2 billion, up 12.2% from the same period last year, breaking road forecasts. Meanwhile, the adjusted EPS was $6.08, up 6.1% year-on-year, surpassing analyst estimates. However, the decline in inventory was driven by rising healthcare costs, and higher than expected utilization in long-term care and behavioral health led to the healthcare ratio rising to 89.2%.
In contrast, Centene Corporation (CNC) is lagging behind the MOH strains. CNC stocks fell nearly 9% on a YTD basis, down 16.9% over the past 52 weeks.
MOH has a slower performance compared to SPX, but analysts are moderately optimistic about its outlook. The stock has a “medium buy” consensus rating from 16 analysts covering it, currently below the average price target of 358.64.
On the date of publication, Sohini Mondal had no position (directly or indirectly) in any of the securities mentioned in this article. All information and data in this article is for informational purposes only. This article was originally published barchart.com